Rankings
▼
Calendar
ESPR Q4 2015 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$519M
Q4 2015 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-0.58
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$9M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$296M
Total Liabilities
$8M
Stockholders' Equity
$287M
Cash & Equivalents
$77M
← FY 2015
All Quarters
Q1 2016 →
